Summary
Overview
Work History
Education
Certification
Timeline
Generic

Yvette Heinrichson

San Diego,CA

Summary

Strategic, highly accomplished corporate accounting and finance executive with proven track record in planning and implementing efficient, structured, and compliant financial and accounting systems. Using my extensive experience in accounting, financial reporting and financial planning, I deliver comprehensive and independent insight to support and streamline business processes to achieve sustainable growth and efficiency. I thrive in fast-paced environments, consistently delivering high-quality results under tight deadlines and am adept at leveraging technology and analytics to enhance financial performance and decision-making. Competent communicator at presenting complex financial information to stakeholders at all levels. Additional strengths include

Overview

20
20
years of professional experience
1
1
Certification

Work History

Managing Director

FINANSERV, LLC
San Diego, CA
01.2024 - Current
  • Company Overview: Finanserv provides finance, accounting and financial reporting consulting services to companies in various industries
  • Assist with budgeting, forecasting, and dynamic financial modeling to support strategic decision-making and business growth initiatives
  • Provide technical accounting research and concise documentation of complex issues to ensure accurate accounting treatment
  • Assist with the adoption of new accounting standards and associated process implementation
  • Preparation of quarterly and annual external financial reporting, including Forms 10-Q, 10-K, 8-K, and tie- out documentation
  • Advise on the design, implementation, and improvement of accounting systems and internal controls to ensure accuracy, efficiency, and compliance with regulations

Chief Financial Officer

SWK HOLDINGS CORPORATION
San Diego, CA
01.2016 - 01.2024
  • Company Overview: Enteris BioPharma, Inc
  • Is a Wholly-Owned Biopharmaceutical CDMO Subsidiary of SWK Holdings Corporation A publicly traded, specialized finance company focused in global healthcare sector that provides innovative capital solutions to life science companies, institutions, and inventors
  • Collaborated with CEO and other senior management in identifying capital requirements (including baby bond offering) for the Company's growth strategies and negotiating options, including debt and equity, to support strategic initiatives and investments; key participant in exchange uplist from OTC to NASDAQ
  • Lead the budgeting, forecasting and financial analysis process to provide insightful guidance to CEO and other senior management
  • Built and maintained financial data models, reporting systems, and performance metrics to identify business trends and guide data-driven decision-making; built and maintained financial data models for royalty-based financings
  • Established and maintained relationships with institutional investors, investment bankers, underwriters and other key stakeholders; responsible for monthly borrowing base calculations and other support materials
  • Managed day-to-day operations related to accounting, financial reporting, legal, tax compliance, payroll, accounts payable/receivable and human resource functions of the company and its subsidiaries
  • Responsible for the preparation of the quarterly and annual Form 8-K/press release, 10-Q, 10-K, and Proxy, as well as Section 16 filings; participated alongside CEO in quarterly live earnings calls
  • Established and incorporated continuous improvements to enhance controls, mitigate risks, and ensure compliance with GAAP, SEC, and PCAOB financial reporting standards
  • Monitored and ensured timely identification, impact and compliance with evolving accounting standards and reporting requirements; implemented accounting standards updates (ASC 606 for biopharmaceutical CDMO subsidiary, Enteris BioPharma, Inc.; ASC 842 & 326)
  • Preparation of quarterly board package and audit committee meeting materials
  • Chief Accounting Officer
  • Controller

SEC Reporting Manager

ZS PHARMA, INC.
Coppell, TX
01.2015 - 01.2016
  • Company Overview: A publicly traded biopharmaceutical company focused on using its proprietary ion-trap technology to develop new treatments
  • ZS Pharma, Inc
  • Was acquired by Astra Zeneca Group in December 2015
  • Drafted financial statements and footnote disclosures for quarterly 10-Qs and managed SEC EDGAR filing process
  • Researched and prepared white paper documentation for share-based compensation, revenue recognition, and debt and financing transactions related to accounting

Assistant Controller, SEC Reporting Manager

CVSL INC.
Plano, TX
01.2014 - 01.2015
  • Company Overview: A publicly traded company engaged in the development and acquisition of companies in the micro-enterprise sector
  • Managed accounting, tax, treasury, and accounts payable professionals across active holding and global subsidiary companies that totaled fourteen entities
  • Prepared financial consolidation and drafted quarterly and annual Forms 8-K, 10-Q, and 10-K
  • Developed and documented standard operating procedures and internal controls to support holding company's purchase and integration of eight companies within two years
  • Managed the accounting for CVSL's fourteen companies using disparate systems and devised solutions to address challenges, including issues related to different currencies, chart of accounts, intercompany sales, sales and VAT taxes, accounts payable, and cost accounting

Senior Auditor

DELOITTE
Costa Mesa, CA
01.2005 - 01.2008
  • Company Overview: Deloitte provides industry-leading audit, consulting, tax and advisory services to companies in various industries
  • Performed and documented substantive and analytical audit testing on financial statements at interim and year-end periods
  • Industries included, but not limited to, technology, life sciences, manufacturing and real estate
  • Client service experience included the launch of two public IPOs, as well as beginning balance procedures
  • Provided tax services to public companies in the real estate and airline industries
  • Tax Associate

SEC Reporting Manager

MONOGRAM RESIDENTIAL TRUST, INC.
Plano, TX
01.2015
  • Company Overview: A publicly traded, owner-operator and developer of high-quality apartment communities
  • Monogram Residential Trust, Inc
  • Was acquired by Greystar Real Estate Partners in September of 2017
  • Key participant in the preparation and filing of annual and quarterly reports (Form 8-K, Form 10-K, Form 10-Q), adhering to SEC guidelines, ensuring accuracy and completeness of financial disclosures
  • Collaborated closely with external auditors, legal counsel, and senior management to address complex accounting issues and ensure transparency in financial reporting
  • Researched and applied complex accounting standards to prepare technical memorandum

Education

Bachelor of Science - Business Administration & Accounting

SAN FRANCISCO STATE UNIVERSITY
San Francisco, CA

Certification

Certified Public Accountant, California Board of Accountancy (2010-Present); Certified Fraud Examiner (2020-Present); XBRL Certification; Entrepreneurial Operating System (EOS) Leadership Training Model

Timeline

Managing Director

FINANSERV, LLC
01.2024 - Current

Chief Financial Officer

SWK HOLDINGS CORPORATION
01.2016 - 01.2024

SEC Reporting Manager

ZS PHARMA, INC.
01.2015 - 01.2016

SEC Reporting Manager

MONOGRAM RESIDENTIAL TRUST, INC.
01.2015

Assistant Controller, SEC Reporting Manager

CVSL INC.
01.2014 - 01.2015

Senior Auditor

DELOITTE
01.2005 - 01.2008

Certified Public Accountant, California Board of Accountancy (2010-Present); Certified Fraud Examiner (2020-Present); XBRL Certification; Entrepreneurial Operating System (EOS) Leadership Training Model

Bachelor of Science - Business Administration & Accounting

SAN FRANCISCO STATE UNIVERSITY
Yvette Heinrichson